Načítá se...
Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial
AIM: To assess the role of the (13)C-methacetin breath test (MBT) in patients with acute liver disease. METHODS: Fifteen patients with severe acute liver disease from diverse etiologies were followed-up with (13)C-MBT during the acute phase of their illnesses (range 3-116 d after treatment). Patient...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The WJG Press and Baishideng
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2653395/ https://ncbi.nlm.nih.gov/pubmed/19248196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.966 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|